Biopharma

Deputy director of FDA’s CBER departs amid mass exodus ...

Celia Witten, M.D., Ph.D., is no longer deputy director of the FDA’s Center for ...

STAT+: Maryland lawmakers vote to expand powers of the ...

The Maryland House of Delegates has voted overwhelmingly to allow a state board ...

Epidural Steroid Injections Reviewed for Radicular Pain...

FRIDAY, Feb. 21, 2025 -- There is some evidence for epidural steroid injections...

Acalabrutinib-Venetoclax Prolongs Survival in Previousl...

FRIDAY, Feb. 21, 2025 -- For patients with previously untreated chronic lymphoc...

Higher Calcium Intake Linked to Reduced Colorectal Canc...

FRIDAY, Feb. 21, 2025 -- Higher calcium intake is associated with reduced color...

After asset purchase from Travere, Mirum's Ctexli cross...

A little less than two years after San Francisco’s Mirum Pharmaceuticals ponied ...

Roche rolls out new DNA 'sequencing-by-expansion' approach

Roche said its technique combines aspects of DNA synthesis and nanopore-based re...

Abbott's stigma-busting campaign shows how diabetes bia...

A new awareness campaign from Abbott highlights a major sticking point in diabet...

Mass layoffs leave federal employees with disabilities ...

Disabled workers on a two-year probation were especially vulnerable during the T...

Roche rolls out new DNA ‘sequencing-by-expansion’ approach

Roche said its technique combines aspects of DNA synthesis and nanopore-based re...

Systolic BP Target

FRIDAY, Feb. 21, 2025 -- Most older adults in the Systolic Blood Pressure Interv...

Diabetes, Dyslipidemia Screening Rates Low After Pregna...

FRIDAY, Feb. 21, 2025 -- Patients with pregnancy-related hypertension (HTN) or d...

Certain Glucose-Lowering Meds Associated With Lower Ris...

FRIDAY, Feb. 21, 2025 -- For patients with type 2 diabetes (T2D) and chronic obs...

Sisters of Those With Adverse Pregnancy Outcome Also Ha...

FRIDAY, Feb. 21, 2025 -- Women with adverse pregnancy outcomes (APOs) have an in...

Olpasiran Leads to Significant Reduction in Oxidized Ph...

FRIDAY, Feb. 21, 2025 -- Olpasiran, a small interfering RNA, which blocks lipopr...

The power of patient communities: How patient communiti...

Patient communities on social are more than just support networks; they are livi...

Federal judge extends restraining order on Trump admini...

Judge Angel Kelley kept in place an order blocking the Trump administration from...

FDA Approves First Treatment for Cerebrotendinous Xanth...

The FDA approved Ctexli (chenodiol) for the treatment of cerebrotendinous xantho...

Ozempic, Wegovy shortage resolved; Pfizer CEO is PhRMA’...

The FDA determined that Novo Nordisk’s obesity and diabetes drugs were no longer...

MeiraGTx gene therapy allows 11 blind children to see a...

Eleven children who were legally blind at birth all gained visual acuity after r...

Cosette sets sights on women's healthcare stardom with ...

The combined company will offer a diverse portfolio of women's healthcare pills ...

Once valued at $10B, bluebird bio sold to private equit...

Private equity firms Carlyle and SK Capital have agreed to pay $29 million to ac...

Novo Nordisk's semaglutide shortage officially conclude...

The FDA has officially declared an end to the supply squeeze on Novo Nordisk’s G...

Procedural ‘loophole’ leaves NIH grants frozen, despite...

The Trump administration is exploiting an administrative loophole to keep federa...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.